Afstyla – Prelaunch Film
Our job was to prepare the market launch of Afstyla, a treatment drug for haemophilia A patients. The type of campaign our customer CSL Behring was looking for was one that was both emotional and attention-grabbing. The communication was targeted at the entire CSL Behring staff worldwide as well as haematology specialists and haemophilia A patient organisations around the globe. The unique challenge here was that neither the drug itself nor its properties were to be named explicitly in the prelaunch phase.